ECT Reduces Executive Control Deficit: New Study From China
Out on PubMed, from China, is this study: Cognitive Considerations in Major Depression: Evaluating the Effects of Pharmacotherapy and ECT on Mood and Executive Control Deficits. Spagna A, Wang J, Rosario IE, Zhang L, Zu M, Wang K, Tian Y. Brain Sci. 2022 Mar 4;12(3):350. doi: 10.3390/brainsci12030350. PMID: 35326307 The abstract is copied below: Deficits in the executive control of attention greatly impact the quality of life of patients diagnosed with major depressive disorder (MDD). However, attentional deficits are often underemphasized in clinical contexts compared with mood-based symptoms, and a comprehensive approach for specifically evaluating and treating them has yet to be developed. The present study evaluates the efficacy of bifrontal electroconvulsive therapy (ECT) combined with drug therapy (DT) in alleviating mood-related symptomatology and executive control deficits in drug-refractory MDD patients and compares these effects with those observed in MDD patients undergo